Cargando…

Soluble angiotensin‐converting enzyme 2 is transiently elevated in COVID‐19 and correlates with specific inflammatory and endothelial markers

The main entry receptor of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is angiotensin‐converting enzyme 2 (ACE2). SARS‐CoV‐2 interactions with ACE2 may increase ectodomain shedding but consequences for the renin‐angiotensin system and pathology in Coronavirus disease 2019 (COVID‐19)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lundström, Annika, Ziegler, Louise, Havervall, Sebastian, Rudberg, Ann‐Sofie, von Meijenfeldt, Fien, Lisman, Ton, Mackman, Nigel, Sandén, Per, Thålin, Charlotte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426677/ https://www.ncbi.nlm.nih.gov/pubmed/34138483 http://dx.doi.org/10.1002/jmv.27144

Ejemplares similares

Prothrombotic changes in patients with COVID‐19 are associated with disease severity and mortality
por: von Meijenfeldt, Fien A., et al.
Publicado: (2020)

Elevated factor V activity and antigen levels in patients with Covid‐19 are related to disease severity and 30‐day mortality
por: von Meijenfeldt, Fien A., et al.
Publicado: (2021)

Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge
por: von Meijenfeldt, Fien A., et al.
Publicado: (2021)

Sustained prothrombotic changes in convalescent patients with COVID-19
por: von Meijenfeldt, Fien A, et al.
Publicado: (2021)

Unravelling the Role of Neutrophil Extracellular Traps in Acute Liver Failure
por: von Meijenfeldt, Fien A., et al.
Publicado: (2022)

IL-6 signalling biomarkers in hospitalised patients with moderate to severe SARS-CoV-2 infection in a single centre study in Sweden
por: Ziegler, Louise, et al.
Publicado: (2022)

Elevated Plasma Levels of Cell‐Free DNA During Liver Transplantation Are Associated With Activation of Coagulation
por: von Meijenfeldt, Fien A., et al.
Publicado: (2018)

A clinical practice-based evaluation of the RIETE score in predicting occult cancer in patients with venous thromboembolism
por: Rosell, Axel, et al.
Publicado: (2019)

Prophylactic fresh frozen plasma and platelet transfusion have a prothrombotic effect in patients with liver disease
por: von Meijenfeldt, Fien A., et al.
Publicado: (2020)

Heparins have adequate ex vivo anticoagulant effects in hospitalized patients with cirrhosis
por: van den Boom, Bente P., et al.
Publicado: (2021)

In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID‐19 patients on anticoagulation
por: Blasi, Annabel, et al.
Publicado: (2020)

Generation of neutrophil extracellular traps in patients with acute liver failure is associated with poor outcome
por: von Meijenfeldt, Fien A., et al.
Publicado: (2021)

Circulating H3Cit is elevated in a human model of endotoxemia and can be detected bound to microvesicles
por: Paues Göranson, Sofie, et al.
Publicado: (2018)

Soluble angiotensin-converting enzyme 2 association with lipid metabolism
por: Nagatomo, Izumi, et al.
Publicado: (2022)

Prognostic value of circulating markers of neutrophil activation, neutrophil extracellular traps, coagulation and fibrinolysis in patients with terminal cancer
por: Rosell, Axel, et al.
Publicado: (2021)

Angiotensin-Converting Enzyme-2
por: Clarke, Nicola E., et al.
Publicado: (2013)

Commentary on “The suboptimal fibrinolytic response in COVID‐19 is dictated by high PAI‐1”
por: von Meijenfeldt, Fien A.
Publicado: (2022)

Angiotensin-converting enzyme 2 and new insights into the renin–angiotensin system
por: Lambert, Daniel W., et al.
Publicado: (2008)

Determination of soluble angiotensin-converting enzyme 2 in saliva samples and its association with nicotine
por: Bru, Samuel, et al.
Publicado: (2023)

Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016)

Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021)

Neutrophil extracellular traps in patients with liver cirrhosis and hepatocellular carcinoma
por: Zenlander, Robin, et al.
Publicado: (2021)

Tissue factor activity of small and large extracellular vesicles in different diseases
por: Sachetto, Ana T.A., et al.
Publicado: (2023)

Diagnostic value of elevated serum angiotensin-converting enzyme and lymphopenia in patients with granulomatous hepatitis
por: El Jammal, Thomas, et al.
Publicado: (2023)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism
por: Meurs, Kathryn M, et al.
Publicado: (2017)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
por: Vio, Carlos P., et al.
Publicado: (2020)

Determinants of soluble angiotensin-converting enzyme 2 concentrations in adult patients with complex congenital heart disease
por: Raedle-Hurst, Tanja, et al.
Publicado: (2020)

On the essentiality of the angiotensin converting enzyme 2 receptor for SARS‐CoV‐2 infection and the potential of soluble angiotensin converting enzyme 2 proteins as universal approach for variants causing COVID‐19
por: Hassler, Luise, et al.
Publicado: (2022)

Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Gersh, Felice L.
Publicado: (2020)

Circulating plasma angiotensin-converting enzyme 2 concentration is elevated in patients with kidney disease and diabetes
por: Sama, Iziah E, et al.
Publicado: (2020)

Prognostic value of elevated plasma angiotensin-converting enzyme 2 in cardiometabolic diseases: A review
por: Zhou, Gang, et al.
Publicado: (2023)

In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Renin‐angiotensin aldosterone profile before and after angiotensin‐converting enzyme‐inhibitor administration in dogs with angiotensin‐converting enzyme gene polymorphism
por: Adin, Darcy, et al.
Publicado: (2020)

Concentrations of Soluble Angiotensin Converting Enzyme 2 (sACE2) in Children and Adults with and without COVID-19
por: Wissing, Sarah Isabella, et al.
Publicado: (2022)

Angiotensin-Converting Enzyme Inhibitors and Angioedema
por: Sánchez-Borges, Mario, et al.
Publicado: (2010)

Angiotensin-converting Enzyme Genetic Polymorphism
por: Wiwanitkit, Somsri, et al.
Publicado: (2014)

Angiotensin converting enzime inhibitors : past, present and beyond /
Publicado: (1989)

Elevated mid-pregnancy plasma levels of angiotensin-converting enzyme 2 in women prior to the development of preeclampsia
por: Junus, Katja, et al.
Publicado: (2022)

Abalone Viscera Fermented with Aspergillus oryzae 001 Prevents Pressure Elevation by Inhibiting Angiotensin Converting Enzyme
por: Iwamoto, Natsumi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t62mccgf0kohtma92csv6l096c